Why the study?
The development of pulmonary hypertension in heart failure patients increases morbidity and mortality, prompting an examination of recent changes in definitions, diagnosis, and management.
Key points are not available for this paper at this time.
Design
Review article
No takes yet. Share an insight, caveat, or question.
Avoids routine PH-specific therapies in left heart disease; confirms trial failures and leaves open refined subgroup research.
Rao et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: